HT
SAGE

HAP Trading’s Sage Therapeutics SAGE Stock Holding History

HAP Trading’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,982
Closed -$563K – 2693
2021
Q4 		$637K Buy
+14,982
New +$627K 0.02% 610
2021
Q1 		– Sell
-15,452
Closed -$1.27M – 2276
2020
Q4 		$1.34M Buy
+15,452
New +$1.14M 0.04% 350
2019
Q4 		– Sell
-34,062
Closed -$4.19M – 1434
2019
Q3 		$4.78M Buy
+34,062
New +$5.7M 0.39% 51

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

HAP Trading's SAGE Position: Q1 2022 in Review

HAP Trading sold out of Sage Therapeutics (SAGE) in Q1 2022, closing a stake of 14,982 shares — an estimated $563K sold.

HAP Trading first reported a position in SAGE in Q3 2019 and held it in 3 quarters. The position peaked at $4.78M in Q3 2019. 211 funds tracked by Wall St. Rank hold SAGE as of Q1 2022.

  • HAP Trading reported no remaining Sage Therapeutics position as of Q1 2022 after selling out during the quarter.
  • HAP Trading sold 14,982 Sage Therapeutics shares in Q1 2022, an estimated $563K.
  • HAP Trading first reported a position in Sage Therapeutics in Q3 2019 and held it in 3 quarters.
  • HAP Trading's Sage Therapeutics position peaked at $4.78M in Q3 2019.
  • 211 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.